antineoplastic agents
DESCRIPTION
ANTINEOPLASTIC AGENTS. PATHOLOGY PHARMACOLOGY. LECTURE 9. Neoplasia. New growth - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/1.jpg)
ANTINEOPLASTIC AGENTSLECTURE 9
PATHOLOGYPHARMACOLOGY
![Page 2: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/2.jpg)
Neoplasia
• New growth• Abnormal mass of tissue the growth of which
exceeds and is uncoordinated in comparison to that of the normal tissue and continues even in the absence of the stimulus that initiated the growth of the tissue in this manner.
• Clinically divided into benign and malignant types
![Page 3: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/3.jpg)
Malignant Neoplasia
• Innocent• Localized• Small, demarcated, well
differentiated• Surgical removal• Can progress to
malignancy• Nomenclature:suffix –oma• Examples: Fibroma,
lipoma, osteoma, meningioma, papilloma (glands), hepatoma, etc
Benign Neoplasia
• Common terms-cancer or crab-due to their strong adherence properties
• Can affect neighboring and far away tissues (metastasis)
• Large, poor demarcation, faster growth, invasive
• Drug treatment plus surgery• No specific nomenclature: • Suffix –sarcoma/ carcinoma for
mesenchymal tissue like fibrosarcoma, squamous cell carcinoma, adenocarcinoma, HCC, etc• Leukemia, lymphoma, etc
![Page 4: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/4.jpg)
![Page 5: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/5.jpg)
Clinical Characteristics- To decide the candidature of cancer chemotherapy
1. Differentiation and Anaplasia - Benign tumors are well differentiated to perform the normal functions of the tissue. Malignancies are anaplastic (anaplasia-dedifferentiated) and pleomorphic. (Not to be confused with dysplasia – abnormal but non-malignant malfunctioning)
![Page 6: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/6.jpg)
2. Rate of growth
Low risk: Low grade, well differentiated tumour, Gleason score 2–6
Intermediate risk: Intermediate grade, moderately differentiated, Gleason score 7
High risk: High grade, poorly differentiated, Gleason score 8–10
3-10
![Page 7: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/7.jpg)
3. Local invasion (staging)
2-4
![Page 8: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/8.jpg)
4. Metastasis
![Page 9: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/9.jpg)
ETIOLOGY
• Geographical – sun, UV, oxygen deficiency• Environmental – asbestos, benzene, phenol• Age – breast, prostrate• Hereditary – protooncogenes, tumour
suppressor genes, DNA repair• Acquired – hyperplastic, dysplastic, gastritis
induced, leukoplakia (betel leaf)
![Page 10: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/10.jpg)
CELL CYCLE AND CANCER
![Page 11: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/11.jpg)
Apoptosis
Oncogenes
Tumor Suppressor
Inv. and Mets
Angiogenesis
Cell cycle
CURRENT TARGETS
![Page 12: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/12.jpg)
12
MOLECULAR BASIS OF CANCER
![Page 13: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/13.jpg)
POSSIBLE CHECKPOINTS FOR RETARDING CANCER
GROWTH
![Page 14: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/14.jpg)
PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
NEXT LECTURE
![Page 15: ANTINEOPLASTIC AGENTS](https://reader035.vdocuments.mx/reader035/viewer/2022062218/568166ae550346895ddaa610/html5/thumbnails/15.jpg)
THANK YOU